Back to Search
Start Over
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
- Source :
-
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2002 Jun 15; Vol. 165 (12), pp. 1581-6. - Publication Year :
- 2002
-
Abstract
- Fibrosing alveolitis associated with systemic sclerosis (FASSc) has a better prognosis than idiopathic pulmonary fibrosis. In view of recent reports that idiopathic nonspecific interstitial pneumonia (NSIP) has a better prognosis than idiopathic usual interstitial pneumonia (UIP), we classified histologic appearances of surgical lung biopsies performed in 80 patients with FASSc. NSIP (n = 62, 77.5%), subcategorized as cellular NSIP (n = 15) and fibrotic NSIP (n = 47) was much more prevalent than UIP (n = 6), end-stage lung disease (ESL, n = 6), or other patterns (n = 6). There were 25 deaths (NSIP 16/62, 26%; UIP/ESL 6/12, 50%). Five-year survival differed little between NSIP (91%) and UIP/ESL (82%); mortality was associated with lower initial carbon monoxide diffusing capacity (DL(CO)) and FVC levels (p = 0.004 and p = 0.007, respectively). Survival and serial FVC and DL(CO) trends did not differ between cellular and fibrotic NSIP. Increased mortality in NSIP was associated with lower initial DL(CO) levels (p = 0.04), higher BAL eosinophil levels (p = 0.03), and deterioration in DL(CO) levels during the next 3 years (p < 0.005). We conclude that NSIP is the histopathologic pattern in most patients with FASSc. However, outcome is linked more strongly to disease severity at presentation and serial DL(CO) trends than to histopathologic findings.
- Subjects :
- Adult
Aged
Anti-Inflammatory Agents therapeutic use
Biopsy
Bronchoalveolar Lavage Fluid cytology
Female
Follow-Up Studies
Humans
Immunosuppressive Agents therapeutic use
Leukocytes metabolism
London
Lung pathology
Male
Middle Aged
Predictive Value of Tests
Prognosis
Pulmonary Diffusing Capacity physiology
Pulmonary Fibrosis diagnosis
Pulmonary Fibrosis mortality
Respiratory Function Tests
Retrospective Studies
Scleroderma, Systemic diagnosis
Scleroderma, Systemic mortality
Severity of Illness Index
Steroids
Survival Analysis
Treatment Outcome
Vital Capacity physiology
Pulmonary Fibrosis etiology
Scleroderma, Systemic complications
Subjects
Details
- Language :
- English
- ISSN :
- 1073-449X
- Volume :
- 165
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- American journal of respiratory and critical care medicine
- Publication Type :
- Academic Journal
- Accession number :
- 12070056
- Full Text :
- https://doi.org/10.1164/rccm.2106012